Akebia Therapeutics, Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

2.090

-0.030 (-1.42%)

At close: Nov 4, 2025, 4:00 PM EST

2.100

+0.010 (0.48%)

Pre-market: Nov 5, 2025, 4:38 AM EST

Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Nov '25 Nov 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	554	415	234	106	395	405	Upgrade
Market Cap Growth	98.12%	77.46%	120.08%	-73.16%	-2.30%	-46.16%	Upgrade
Enterprise Value	613	484	301	121	363	241	Upgrade
Last Close Price	2.09	1.90	1.24	0.58	2.26	2.80	Upgrade
Forward PE	261.25	-	-	-	-	-	Upgrade
PS Ratio	2.38	2.59	1.20	0.36	1.87	1.37	Upgrade
PB Ratio	18.81	-8.43	-7.64	20.30	5.34	1.63	Upgrade
P/TBV Ratio	-	-	-	-	-	8.36	Upgrade
EV/Sales Ratio	3.01	3.02	1.55	0.41	1.71	0.82	Upgrade
EV/EBITDA Ratio	26.24	-	-	39.44	-	-	Upgrade
Debt / Equity Ratio	6.70	-3.84	-4.72	30.07	2.56	0.51	Upgrade
Debt / EBITDA Ratio	6.91	-	-	18.82	-	-	Upgrade
Asset Turnover	0.72	0.69	0.65	0.66	0.36	0.42	Upgrade
Inventory Turnover	1.69	1.64	2.13	0.77	1.67	0.72	Upgrade
Quick Ratio	1.77	1.07	0.82	1.01	0.79	1.59	Upgrade
Current Ratio	1.98	1.41	1.18	1.43	1.04	1.99	Upgrade
Return on Equity (ROE)	-	-	-	-237.83%	-175.37%	-119.82%	Upgrade
Return on Assets (ROA)	0.88%	-12.49%	-9.30%	-4.89%	-24.27%	-15.41%	Upgrade
Return on Capital (ROIC)	1.69%	-22.81%	-20.14%	-10.17%	-44.71%	-24.88%	Upgrade
Earnings Yield	-6.58%	-16.74%	-22.23%	-88.77%	-71.32%	-95.09%	Upgrade
FCF Yield	-0.46%	-9.82%	-10.01%	-69.03%	-63.99%	-27.35%	Upgrade
Buyback Yield / Dilution	-16.95%	-12.53%	-2.56%	-10.14%	-19.85%	-16.95%	Upgrade

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q